4.7 Article

Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

Frailty Prevalence, Incidence, and Association with Incident Disability in the Italian Longitudinal Study on Aging

Lucia Galluzzo et al.

Summary: This study conducted a systematic analysis of frailty prevalence and incidence in a large cohort of older adults and found that frailty is common among older people and is a strong and independent predictor of disability.

GERONTOLOGY (2023)

Review Peripheral Vascular Disease

Hypertension, Neurovascular Dysfunction, and Cognitive Impairment

Monica M. Santisteban et al.

Summary: Hypertension is a significant risk factor for vascular cognitive impairment and late-life dementia. It induces various harmful effects on cerebral vasculature and can disrupt blood-brain barrier integrity, leading to cognitive impairment.

HYPERTENSION (2023)

Article Medicine, General & Internal

Association between frailty, chronic conditions and socioeconomic status in community-dwelling older adults attending primary care: a cross-sectional study using practice-based research network data

Dee Mangin et al.

Summary: This study aims to investigate the associations between frailty levels and chronic conditions and socioeconomic status. The study found that as frailty levels increased, the prevalence of chronic diseases also increased, and there were significant associations with low income and high material deprivation in the community. Therefore, the study emphasizes the need for a health equity approach in frailty care, and demonstrates the utility and feasibility of collecting patient-level data in primary care to provide targeted interventions for those with the greatest need.

BMJ OPEN (2023)

Article Endocrinology & Metabolism

Diabetes Care in the Hospital: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Older Adults: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023

Nuha A. ElSayed et al.

DIABETES CARE (2023)

Article Cardiac & Cardiovascular Systems

Correlation of physical and cognitive impairment in diabetic and hypertensive frail older adults

Pasquale Mone et al.

Summary: This is the first study to show a significant correlation between 5-m gait speed test and MoCA score in frail diabetic and hypertensive older adults. These results highlight the association between cognitive and physical function, providing valuable information for improving the overall health status of these patients.

CARDIOVASCULAR DIABETOLOGY (2022)

Article Peripheral Vascular Disease

Diastolic Blood Pressure Variability in Later Life May Be a Key Risk Marker for Cognitive Decline

Ruth Peters et al.

Summary: This study found that diastolic blood pressure variability in later life may be a risk marker for cognitive decline.

HYPERTENSION (2022)

Article Transplantation

Chronic kidney disease, physical activity and cognitive function in older adults-results from the National Health and Nutrition Examination Survey (2011-2014)

Nadia M. Chu et al.

Summary: This study found that cognitive function among individuals with chronic kidney disease (CKD) is associated with physical activity. CKD stages G4 and G5 were linked with lower global cognitive function, particularly among those with low physical activity. Clinicians should consider screening older patients with CKD who have low physical activity for cognitive impairment and encourage them to meet physical activity guidelines.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Endocrinology & Metabolism

Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Pasquale Mone et al.

Summary: This study demonstrates the significant beneficial effects of the SGLT2 inhibitor empagliflozin on cognitive and physical impairment in frail older adults with diabetes and HFpEF. The results show improvements in cognitive function as well as physical impairment in the empagliflozin group compared to the metformin and insulin groups.

DIABETES CARE (2022)

Article Medicine, General & Internal

Physical decline and cognitive impairment in frail hypertensive elders during COVID-19

Pasquale Mone et al.

Summary: The study identified a significant correlation between physical and cognitive impairment in frail hypertensive elderly subjects, with age, diabetes, COPD, and gait speed test showing significant associations with MoCA score.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)

Article Peripheral Vascular Disease

Global cognitive function correlates with P-wave dispersion in frail hypertensive older adults

Pasquale Mone et al.

Summary: This study is the first to show that P-wave dispersion is correlated with global cognitive function in frail hypertensive older adults. Hypertension is a leading cause of cognitive decline, and the study found a significant correlation between P-wave dispersion and cognitive function.

JOURNAL OF CLINICAL HYPERTENSION (2022)

Review Endocrinology & Metabolism

Metformin: Is it a drug for all reasons and diseases?

Chris R. Triggle et al.

Summary: Metformin, a commonly used drug for type 2 diabetes, has shown potential therapeutic effects for other diseases such as polycystic ovary syndrome, cancer, and neurodegenerative diseases. However, there is still debate on whether metformin is effective for all diseases and whether its benefits are solely due to its anti-hyperglycemic and insulin-sensitizing effects.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

Article Endocrinology & Metabolism

Hyperglycemia and Physical Impairment in Frail Hypertensive Older Adults

Antonella Pansini et al.

Summary: Hyperglycemia has a significant impact on physical impairment in frail hypertensive older adults, regardless of diabetes mellitus.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Geriatrics & Gerontology

New horizons in life extension, healthspan extension and exceptional longevity

David G. Le Couteur et al.

Summary: Many common chronic diseases and syndromes are ageing-related, and targeting biological changes of ageing with therapeutic agents may prevent or delay multiple diseases. Discovering gerotherapeutic drugs involves similar methods used for discovering drugs for diseases, such as screening for novel compounds or repurposing existing drugs. Studying populations with exceptional longevity is a novel approach to identify genes variants that could be targeted by drugs. Several gerotherapeutics are entering human clinical trials, with more potential drugs being studied in animal models.

AGE AND AGEING (2022)

Article Nutrition & Dietetics

Effects of Diastolic Blood Pressure on Brain Structures and Cognitive Functions in Middle and Old Ages: Longitudinal Analyses

Hikaru Takeuchi et al.

Summary: The study found that high diastolic blood pressure is associated with changes in brain structure and cognitive function, while higher cheese intake is related to reduced diastolic blood pressure and improved cognitive abilities.

NUTRIENTS (2022)

Article Medicine, General & Internal

Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke® and Glucophage®-XR) in healthy Chinese volunteers: a randomized phase I clinical trial

Ming-Li Sun et al.

Summary: The study aimed to evaluate the bioequivalence and safety of generic metformin hydrochloride sustained-release tablets developed in China compared to the innovator product manufactured in the US. Results showed bioequivalence and comparable safety profiles between the two products in healthy Chinese volunteers under fasting conditions.

ANNALS OF MEDICINE (2022)

Review Endocrinology & Metabolism

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials

Katarzyna Nabrdalik et al.

Summary: Metformin is the first-line drug for the treatment of type 2 diabetes, but its use may be associated with gastrointestinal adverse events. This study found through meta-analysis that patients treated with metformin have a higher risk of abdominal pain, nausea, and diarrhea compared to other antidiabetic drugs, and the risk of bloating and diarrhea is higher with immediate-release formulation than with extended-release formulation.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Medicine, General & Internal

Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts

Yanjun Ma et al.

Summary: A comparison of cognitive decline trajectories between individuals with borderline hypertension and normal blood pressure showed no significant difference in decline rate, while those with high blood pressure exhibited significantly faster cognitive decline. Individuals with borderline hypertension may not need to start antihypertensive therapy considering cognitive decline.

BMC MEDICINE (2021)

Review Endocrinology & Metabolism

Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Aedrian A. Abrilla et al.

Summary: The study aimed to compare the efficacy and tolerability of metformin extended-release (MXR) and metformin immediate-release (MIR) in adults with type 2 diabetes mellitus (T2DM). The results showed that MIR was statistically associated with better HbA1c lowering, while MXR only reduced dyspepsia.

DIABETES RESEARCH AND CLINICAL PRACTICE (2021)

Article Endocrinology & Metabolism

Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus

Li-xin Guo et al.

Summary: Metformin hydrochloride sustained-release (SR) tablet (II) produced by Dulening and the original metformin hydrochloride tablet produced by Glucophage exhibit similar therapeutic efficacy in the treatment of T2DM, but the Dulening group has a significantly lower overall incidence of ADRs as well as gastrointestinal ADR compared to the Glucophage group.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Pharmacology & Pharmacy

Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review

Jixue Tan et al.

Summary: A systematic review comparing the effectiveness, safety, and patient compliance between metformin immediate-release (IR) and extended-release (XR) formulations found no significant differences in outcomes. However, metformin XR was associated with improved patient compliance compared to metformin IR.

FRONTIERS IN PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

The impact of metformin on prolactin levels in postmenopausal women

Robert Krysiak et al.

Summary: This study found that the impact of metformin on lactotrope secretory function is partially determined by the estrogen status of patients. Metformin reduced monomeric prolactin levels in women on hormone replacement therapy, but had a less pronounced effect in women not using hormone replacement therapy.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)

Review Urology & Nephrology

Hypertension-induced cognitive impairment: from pathophysiology to public health

Zoltan Ungvari et al.

Summary: Hypertension has significant impacts on cerebral microcirculation which can lead to cognitive impairment, especially in the elderly. Interventions targeting blood pressure reduction, lifestyle changes, and promoting microvascular health have the potential to prevent or delay vascular cognitive impairment and Alzheimer's disease in hypertensive patients.

NATURE REVIEWS NEPHROLOGY (2021)

Review Endocrinology & Metabolism

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

Ibrahim Mohammed et al.

Summary: Metformin, commonly used to treat type 2 diabetes, may have anti-aging potential and improve healthspan by reducing early mortality associated with various diseases. However, the evidence regarding whether metformin can extend lifespan remains controversial.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Geriatrics & Gerontology

Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study

Helen P. Hazuda et al.

Summary: This study suggests that early intensive lifestyle intervention in individuals at high risk of diabetes may reduce the prevalence of frailty in later life, while metformin may not be effective.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2021)

Article Psychology, Developmental

Blood pressure and cognitive decline - the impact of hypertension over one decade

Sarah Sanchez Hoffmann et al.

Summary: This study revealed that having hypertension over 10 years is associated with cognitive decline, and prevalent hypertension with longer exposure time may be more detrimental to cognitive function than temporary hypertension.

AGING NEUROPSYCHOLOGY AND COGNITION (2021)

Article Geriatrics & Gerontology

Rationale and Study Design of a Randomized Clinical Trial of Metformin to Prevent Frailty in Older Adults With Prediabetes

Sara E. Espinoza et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)

Review Cell Biology

Benefits of Metformin in Attenuating the Hallmarks of Aging

Ameya S. Kulkarni et al.

CELL METABOLISM (2020)

Review Endocrinology & Metabolism

Metformin and Its Benefits for Various Diseases

Ziquan Lv et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Peripheral Vascular Disease

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Thomas Unger et al.

HYPERTENSION (2020)

Article Peripheral Vascular Disease

Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension

Monica M. Santisteban et al.

HYPERTENSION (2020)

Article Geriatrics & Gerontology

Frailty Is Inversely Related to Age at Menopause and Elevated in Women Who Have Had a Hysterectomy: An Analysis of the Canadian Longitudinal Study on Aging

Chris P. Verschoor et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)

Review Geriatrics & Gerontology

Metformin as a geroprotector: experimental and clinical evidence

Veronika Piskovatska et al.

BIOGERONTOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Hypertension Management in Older and Frail Older Patients

Athanase Benetos et al.

CIRCULATION RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Neurovascular and Cognitive Dysfunction in Hypertension Epidemiology, Pathobiology, and Treatment

Costantino Iadecola et al.

CIRCULATION RESEARCH (2019)

Article Endocrinology & Metabolism

Frailty and Risk of Fractures in Patients With Type 2 Diabetes

Guowei Li et al.

DIABETES CARE (2019)

Review Biochemistry & Molecular Biology

Insulin Resistance and Oxidative Stress in the Brain: What's New?

Mateusz Maciejczyk et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Endocrinology & Metabolism

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy

Miriam Longo et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Article Geriatrics & Gerontology

Fluctuations in frailty among older adults

Erwin Stolz et al.

AGE AND AGEING (2019)

Review Cardiac & Cardiovascular Systems

Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management

Fei Luo et al.

CARDIOVASCULAR DIABETOLOGY (2019)

Review Geriatrics & Gerontology

Metformin and Aging: A Review

Hartmut H. Glossmann et al.

GERONTOLOGY (2019)

Article Geriatrics & Gerontology

A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores

Nicole Carson et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)

Article Peripheral Vascular Disease

Hypertension and frailty in older adults

Ivan Aprahamian et al.

JOURNAL OF CLINICAL HYPERTENSION (2018)

Article Endocrinology & Metabolism

The Effect of Metformin on Serum Gonadotropin Levels in Postmenopausal Women with Diabetes and Prediabetes: A Pilot Study

Robert Krysiak et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2018)

Review Multidisciplinary Sciences

Metabolic Syndrome and cognitive decline in the elderly: A systematic review

Naima Assuncao et al.

PLOS ONE (2018)

Article Health Care Sciences & Services

Real-world assessment of treatment with extended-release topiramate (Trokendi XR (R)) and comparison with previous immediate-release topiramate treatment

Welton O'Neal et al.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2018)

Article Geriatrics & Gerontology

Montreal cognitive assessment reflects cognitive reserve

Jae Myeong Kang et al.

BMC GERIATRICS (2018)

Review Geriatrics & Gerontology

Sex differences in frailty: A systematic review and meta-analysis

E. H. Gordon et al.

EXPERIMENTAL GERONTOLOGY (2017)

Article Multidisciplinary Sciences

Body Mass Index and Decline of Cognitive Function

Sujin Kim et al.

PLOS ONE (2016)

Editorial Material Cardiac & Cardiovascular Systems

The pleiotropic effects of metformin: time for prospective studies

Daniel I. Bromage et al.

CARDIOVASCULAR DIABETOLOGY (2015)

Review Cell Biology

Metformin: From Mechanisms of Action to Therapies

Marc Foretz et al.

CELL METABOLISM (2014)

Article Geriatrics & Gerontology

Body mass index, lifestyles, physical performance and cognitive decline: The Treviso Longeva (Trelong) study

M. Gallucci et al.

JOURNAL OF NUTRITION HEALTH & AGING (2013)

Review Pharmacology & Pharmacy

Overview of metformin: special focus on metformin extended release

Shamsa Ali et al.

EXPERT OPINION ON PHARMACOTHERAPY (2012)

Article Geriatrics & Gerontology

Prevalence and 10-Year Outcomes of Frailty in Older Adults in Relation to Deficit Accumulation

Xiaowei Song et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)

Article Clinical Neurology

Body mass index and cognitive decline in a biracial community population

M. T. Sturman et al.

NEUROLOGY (2008)

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Article Geriatrics & Gerontology

Frailty in older adults: Evidence for a phenotype

LP Fried et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2001)